Searched for
MEDICINE PRICING COMPLIANCE
Drug cos refuse to take sole responsibility for overpricingIndian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Maharashtra FDA trains guns on overpriced drugsMaharashtra FDA plans to approach the NPPA regarding exorbitant drug prices. The agency is examining data and will take action against unet...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- Elder care for your ageing parents: Which services can you get at what cost and what you need to ask before picking a service providerElder care firms offer vital support for ageing parents of distant children. These companies provide healthcare, companionship, and daily a...
- How to Avoid a False Start When You’re Leading a Big ChangeMany leaders believe the greatest risk in change is moving too slowly. That’s often true. For the times it’s not true, the greatest risk is...
- New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...
- Should they now be part of a long-term investing framework? 7 healthcare stocks with upside potential of up to 25%India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Coronavirus outbreak: Drug price regulator NPPA calls for close watch on Active Pharmaceutical Ingredients availability"The key drug industry associations have assured the government that there is enough stock of Active Pharmaceutical Ingredients APIs/ formu...
- NPPA identifies 634 suspected cases of overchargingAs stipulated under the Drugs (Prices Control) Order (DPCO) 2013, NPPA fixes ceiling price of essential medicines of Schedule I.
- Prices of around 12,000 drug SKUs decline in January: NPPAPrices of around 12,000 stock keeping units (SKUs) of medicines have come down during January this year as a consequence of implementation ...
- Centre for drug price watchdogs in statesThe government plans to spread its regulatory wings to keep prices of medicines under stringent check in every nook and corner of the count...
- All new medicines to come under price controlThe drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to en...
- Life-saving drugs to show government-fixed rates in bold red from January 2015It will enable consumers, who are presently highly dependent on doctors and chemists, to make an informed choice while purchasing medicines.
- NPPA moots online check as remedy for overpricingThe drug price regulator is setting up a nationwide electronic price monitoring system in a bid to detect overcharging with the click of a ...
- Imported drugs get six-month extension for MRP complianceIt will take six more months before you see the maximum retail price (MRP), inclusive of local taxes, printed on consumer packs of imported...
Load More
